Search results
Promising Trial Results Show New Standards In Cancer Treatment And Diagnostics Are On The Horizon
Benzinga via Yahoo Finance· 23 hours ago(NASDAQ: MRNA) and Merck & Co (NYSE: MRK) also reported durable efficiency of their combined...
Study shows new cancer vaccine to treat melanoma has 96% survival rate
UNILAD· 24 hours agoA new vaccine treatment for skin cancer melanoma has shown extremely promising results in a new...
Immunotherapy drug may keep colon cancer patients cancer-free after surgery
UPI· 2 days agoDoctors in Britain say that an immunotherapy drug, given before surgery, can help many more colon...
What To Know About Personalized mRNA Cancer Vaccines After Promising Trials From Moderna And Merck
Forbes· 1 day agoMerck and Moderna released “extremely impressive” positive data from a mid-stage trial of the...
Experimental mRNA vaccines gain steam with promising cancer trial results
Semafor via Yahoo News· 2 days agoMelanoma patients who received monthly mRNA vaccines and Merck’sKeytruda immunotherapy had lower...
... 3-Year Data For mRNA-4157 (V940) in Combination With KEYTRUDA(R) (pembrolizumab) Demonstrated...
Digital Journal· 2 days agoAt a median planned follow-up of the Phase 2b study at 34.9 months, mRNA-4157 (V940) in combination with KEYTRUDA reduced the risk of recurrence or death by 49% and the risk ...
A shot in the arm that can help fight cancer? How vaccine trials are showing promise.
USA TODAY via Yahoo News· 1 day agoThe new data in patients with advanced melanoma, a type of skin cancer, shows that three years after...
Experimental Therapy Shows Promise in Pancreatic C | Newswise
Newswise· 6 days agoImmunotherapy drugs alone have not shown to be responsive to pancreatic cancer. The findings were presented at the American Society of Clinical Oncology 2024 annual meeting ...
Neoadjuvant Strategy Establishes Standard of Care for Resectable Stage III Melanoma
MedPage Today· 1 day agoCombination neoadjuvant immunotherapy for resectable melanoma reduced recurrence and other clinical...
Moderna, Merck say vaccine improved survival in patients with deadly skin cancer
CNBC· 2 days agoModerna and Merck released more positive three-year data Monday on their experimental vaccine, given...